How can artificial intelligence advance healthcare?

Artificial intelligence is poised to fundamentally change healthcare. To find out the current state of research and the challenges that lie ahead, anyone interested can attend the first symposium of the Artificial Intelligence in Digital Health (AIDHeal) Network on January 28, 2022.

Joint press release by the University of Potsdam, the Hasso Plattner Institute, the Max Delbrück Center for Molecular Medicine and Humboldt-Universität zu Berlin

The first AIDHeal Symposium will provide insights into current research on the use of artificial intelligence (AI) techniques in healthcare. Experts from Berlin-Brandenburg and around the world are coming together to discuss cutting-edge AI applications in molecular medicine and clinical practice and to explore how digital health technologies will develop in the future.

The online symposium is aimed at scientists from the basic and applied sciences, at engineering and software development experts, and at medical professionals from all disciplines and levels of experience. Students and PhD candidates as well as interested citizens are also invited to participate in the discussion. The AIDHeal Symposium is organized by the Digital Engineering Faculty and the Potsdam Graduate School of the University of Potsdam, the Hasso Plattner Institute (HPI), the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Humboldt-Universität zu Berlin (HU Berlin). The symposium will be held in English.

Renowned experts like Dr. Marina Höhne from Technische Universität Berlin, Professor Ariel Dora Stern from the Hasso Plattner Institute and Harvard Business School, and Professor Thomas Fuchs from the Icahn School of Medicine at Mount Sinai, will speak about their current research. Their work touches on key challenges facing our society: What potential does AI have to better understand the causes and effects of disease? How can we use neural networks to improve the predictive power of AI? And what will the healthcare of tomorrow look like? There will also be a series of short talks on artificial intelligence and digital health. Professor Oliver Günther, President of the University of Potsdam, and Professor Thomas Sommer, interim Scientific Director of the MDC, will open the symposium.

Digital Healthcare, Made in Germany

The newly formed AIDHeal Network, led by spokespersons Professor Christoph Lippert (HPI), Professor Thoralf Niendorf (MDC) and Professor Sonja Greven (HU Berlin), aims to bring together expertise on data science, machine learning, artificial intelligence and digital health in Berlin-Brandenburg. It also seeks to intensify research activities and create new training opportunities in order to increase the international visibility and competitiveness of Digital Healthcare, Made in Germany.

The AIDHeal Network is comprised of the University of Potsdam, the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Technische Universität Berlin, the Berlin Institute for Health at Charité, the German National Cohort, the Hasso Plattner Institute, the Weierstrass Institute for Applied Analysis and Stochastics, Berlin Research 50, the Helmholtz Information & Data Science Academy and numerous industry partners.

Date and time

January 28, 2022, 9:30 a.m. – 3:00 p.m., online

Weiterführende Informationen


Prof. Christoph Lippert
University of Potsdam und Hasso Plattner Institute

Prof. Thoralf Niendorf
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

Prof. Sonja Greven
Humboldt-Universität zu Berlin

Dr. Joannes Freudenreich
University of Potsdam / Potsdam Graduate School
+49 331-977-1580

Dr. Jana Scholz
Press Officer
University of Potsdam
+49-331-977-1474 or -1130

Jana Schlütter
Editor, Communications Department
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
+49- 30-9406-2121 and

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)


The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) is one of the world’s leading biomedical research institutions. Max Delbrück, a Berlin native, was a Nobel laureate and one of the founders of molecular biology. At the MDC’s locations in Berlin-Buch and Mitte, researchers from some 60 countries analyze the human system – investigating the biological foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts the dynamic equilibrium in a cell, an organ, or the entire body, we can prevent diseases, diagnose them earlier, and stop their progression with tailored therapies. Patients should benefit as soon as possible from basic research discoveries. The MDC therefore supports spin-off creation and participates in collaborative networks. It works in close partnership with Charité – Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and the German Center for Cardiovascular Research (DZHK). Founded in 1992, the MDC today employs 1,600 people and is funded 90 percent by the German federal government and 10 percent by the State of Berlin.